These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24386765)

  • 1. The risk of bisphosphonate-related osteonecrosis of the jaw in children. A case report and literature review.
    Ngan KK; Bowe J; Goodger N
    Dent Update; 2013 Nov; 40(9):733-4, 736-8. PubMed ID: 24386765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case.
    Milano M; Wright T; Loechner KJ
    Pediatr Dent; 2011; 33(4):349-52. PubMed ID: 21903004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaws and its relevance to children--a review.
    Christou J; Johnson AR; Hodgson TA
    Int J Paediatr Dent; 2013 Sep; 23(5):330-7. PubMed ID: 23869707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of bisphosphonate patients developing bisphosphonate-related osteonecrosis of the jaw attending an OMFS department.
    Serrant PS; Clark S
    Dent Update; 2013 Nov; 40(9):740-2. PubMed ID: 24386766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A; Almas K; Javed F
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw.
    Maines E; Monti E; Doro F; Morandi G; Cavarzere P; Antoniazzi F
    J Bone Miner Metab; 2012 Jul; 30(4):434-8. PubMed ID: 22065238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review.
    Maciel AP; Quispe RA; Martins LJO; Caldas RJ; Santos PSDS
    Sao Paulo Med J; 2020; 138(4):326-335. PubMed ID: 32725058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
    Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.
    Goodwin JS; Zhou J; Kuo YF; Baillargeon J
    Mayo Clin Proc; 2017 Jan; 92(1):106-113. PubMed ID: 27876314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
    J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of bisphosphonates in children: review of the literature and guidelines for dental management.
    Bhatt RN; Hibbert SA; Munns CF
    Aust Dent J; 2014 Mar; 59(1):9-19. PubMed ID: 24495226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
    Ishikawa T
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Taylor T; Bryant C; Popat S
    Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study.
    Siebert T; Jurkovic R; Statelova D; Strecha J
    J Oral Implantol; 2015 Jul; 41 Spec No():360-5. PubMed ID: 24041299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
    Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.